Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

inal tract (29%), allergic rhinitis (29%), acne-like skin inflammation (25%), pharyngitis or inflammation of the pharynx (25%), vomiting (25%), abnormal behavior (21%), cough (21%), dry skin (21%), scratching of the skin (21%), external ear infection (21%) and skin infection (21%). The most common Grade 3 AEs (with an incidence of at least 5%) were stomatitis or mouth sores, convulsion and decreased neutrophil count. In addition, single cases of Grade 3 sinusitis, pneumonia, viral bronchitis, gastroenteritis or inflammation of the gastrointestinal tract, limb abscess, aspiration, cyclic neutropenia, post lumbar puncture syndrome, sleep apnea syndrome and dizziness were reported. A single case of Grade 4 convulsion was reported. Adverse events were mostly Grade 1 (mild) or Grade 2 (moderate) in severity and were consistent with those previously reported at six months(11).

About everolimusIn the US, Afinitor® (everolimus) tablets is approved to treat patients with SEGA associated with TS who require therapeutic intervention but are not candidates for curative surgical resection. The effectiveness of everolimus is based on an analysis of change in SEGA volume. Clinical benefit such as improvement in disease-related symptoms or increase in overall survival has not been shown. Everolimus is approved in Switzerland as Votubia® (everolimus) tablets for the treatment of patients three years of age and older, with SEGA associated with TS, for whom surgery is not a suitable option. Should everolimus be approved in the EU, the trade name will be Votubia.

Afinitor is approved in the US and Switzerland for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib and also in the EU for the treatment of patients with advanced RCC whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted therapy.

Afinitor is approved in the US f
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... 31, 2015 BioLight ... BLGTY) ("BioLight" or the "Company"), a firm that ... ophthalmology and cancer diagnostics, today announced that its ... identified several new genetic markers with high potential ... treated with bisphosphonate drugs and was able to ...
(Date:8/31/2015)... Premune and Innovet ... licensing agreement for Redonyl ® Ultra. The product, ... veterinary dermatology market, is a nutritional supplement based on ... in dogs and cats. Redonyl ® Ultra is ... has been received positively in the country by veterinarians ...
(Date:8/31/2015)... DUBLIN , Aug. 31, 2015 ... the addition of the "Prescription Pain Drugs ... Medical Marijuana - Global Markets, Competitors and Opportunities: ... to their offering. Pain is ... associated with actual or potential tissue damage. At ...
Breaking Medicine Technology:BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
(Date:8/31/2015)... New York (PRWEB) , ... August 31, 2015 , ... ... autumn, when play-offs and the World Series will dominate the sports world. Fans desire ... and eventually advance to the final series. For children, especially those who are too ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Month 2015 in September by sharing the facts about the role of heredity ... and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions to have both ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... airway management device that could effectively deliver oxygen with a lower risk of ... a better way, I invented the Adam Device." , The Adam Device offers ...
(Date:8/31/2015)... , ... August 31, 2015 , ... A year ago ... team is preparing to release a new issue commemorating the successful first year. ... they need for a potentially difficult time in their lives,” says Melissa Wolfert, founding ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... the use of health IT to create efficiencies in healthcare information exchange, announces ... . Taking place at the Hyatt Regency Reston in Reston, Va. from October ...
Breaking Medicine News(10 mins):Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:InventHelp® Client's Invents Medical Device to Restore Respiratory Function (BGF-905) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3
... WASHINGTON, Nov. 20 POLITICO recently published an ... America (PhRMA) Senior Vice President Ken Johnson. In the ... PhRMA,s commitment to supporting this historic effort. , Johnson states ... growing and reiterates PhRMA,s position that everyone in ...
... , LOS ANGELES, Nov. 20 As we approach ... people in Los Angeles sadly don,t have enough to eat. To ... of Philadelphia. Children, workers, people you see every day are hungry ... continues to increase. , The Jewish Federation of Greater Los ...
... be removed by surgery) liver cancer, an interventional radiology ... a liver transplant may significantly increase a patient,s chance ... the December issue of the American Journal of ... most common cancer in the world and is responsible ...
... adults who have alcohol dependence problems drink significantly more than ... has found. The findings suggest that older problem drinkers ... drink even more than younger abusers to achieve the effects ... adults over age 60 who have alcohol dependence drink more ...
... Patient Advocate Foundation (PAF) is a national, non-profit ... with chronic, life-threatening and debilitating diseases. Last year, ... 9.5 million contacts for information. PAF,s companion ... national, non-profit organization dedicated to the mission of creating ...
... ... the Dobbs Ferry Pavilion of St. John,s Riverside Hospital announced it has been granted a ... Breast Center is the only medical facility in Westchester County - and one of only ... ...
Cached Medicine News:Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 2Health News:The Jewish Federation Unveils Blueprint to End Hunger in Los Angeles 3Health News:Older problem drinkers use more alcohol than do their younger counterparts 2Health News:Statement by the Scientific Advisory Board of the Patient Advocate Foundation/National Patient Advocate Foundation on Changes to the USPSTF Mammography Guidelines 2Health News:Ashikari Breast Center Receives Full Accreditation from National Accreditation Program for Breast Centers 2Health News:Ashikari Breast Center Receives Full Accreditation from National Accreditation Program for Breast Centers 3
Silicone Elastomer-Coated Latex Foley Catheters 2-Way (Pediatric)...
Midstream Catch Kits...
Midstream Catch Kits...
... BVM 6500 enables physicians ... determine UEBW (ultrasound estimated ... volume using 3-dimensional V-mode ... was designed to assist ...
Medicine Products: